Improving PCOR Methods: Causal Inference

Slides:



Advertisements
Similar presentations
Engaging Patients and Other Stakeholders in Clinical Research
Advertisements

1 Engagement at PCORI: An Overview M. Suzanne Schrandt, JD Deputy Director of Patient Engagement.
National Coalition for Cancer Survivorship Meeting, Washington DC November 13, 2014 Steven Clauser, PhD, MPA Program Director, Improving Healthcare Systems.
1 GHS Research Lecture Series Greenville, SC June 10, 2014 Linda Crew McNamara, RN, MBA PSDTO Advisory Panel & Stakeholder Reviewer Patient-Centered Outcomes.
So You Want to Do Comparative Effectiveness Research? The Nuts and Bolts of CER.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Sue Sheridan, Acting Director, Patient.
Topic Generation and Research Prioritization Joe V. Selby, MD, MPH, Executive Director Rachael Fleurence, PhD, Scientist Rick Kuntz, MD, MSc, Chair, PDC.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Presenter-Dr. L.Karthiyayini Moderator- Dr. Abhishek Raut
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Putting the Patient at the Center of Health Care Research Joe Selby, MD, MPH Executive Director, Patient-Centered Outcomes Research Institute The Conference.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
PCORI Update: Lenore Arab, PhD, MS Value of Information: Starting the Discussion Doug Bell, MD, PhD 12/04/2012.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
The HMO Research Network (HMORN) is a well established alliance of 18 research departments in the United States and Israel. Since 1994, the HMORN has conducted.
PCORI: Studying What Works for Whom Greg Martin Deputy Director, Stakeholder Engagement October 14, 2015.
Improving Clinical Processes: The Million Hearts ® Hypertension Control Change Package for Clinicians Erica K. Taylor, PhD, MPH, MA Million Hearts ® Minority.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
1 Maximizing the Impact of Comparative Effectiveness Research: The Role of the DEcIDE Consortia Scott R. Smith, PhD AHRQ Center for Outcomes & Evidence.
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
PRACTICE TRANSFORMATION NETWORK 2/24/ Transforming Clinical Practice Initiative (TCPI) Practice Transformation Network (PTN)  $18.6 million –
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
April 13, 2015 Patient Engagement and Funding Opportunities.
PRAGMATIC Study Designs: Elderly Cancer Trials
Expanding the Role of the Pharmacist Enhancing Performance in Primary Care through Implementation of Comprehensive Medication Management.
Clinical Quality Improvement: Achieving BP Control
Tim Friede Department of Medical Statistics
Putting it all together CIMPOD 2017, February 27-28
Improving PCOR Methods: Causal Inference
Translating Research Into Practice: Pragmatic Research Approaches
An Analysis of D&I Applications
Developing a guideline
Presentation Developed for the Academy of Managed Care Pharmacy
Module 3: Orientation to Research
Research Questions Does integration of behavioral health and primary care services, compared to simple co-location, improve patient-centered outcomes in.
Heather Allore PhD Yale School of Medicine & School of Public Health
Right-sized Evaluation
MUHC Innovation Model.
Statistical Approaches to Support Device Innovation- FDA View
Clinical Studies Continuum
Randomized Trials: A Brief Overview
Strategies to incorporate pharmacoeconomics into pharmacotherapy
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
What can implementation research offer?
Research Program Strategic Plan
MULTIMORBIDITY: THE MOST COMMON CHRONIC CONDITION
Find and Treat All Missing Persons with TB
Matthew H. Liang, MD Malcolm P. Rogers, MD Ira R. Katz, MD, PhD
Greater Columbia ACH Board of Directors 4/19/17
Presentation Developed for the Academy of Managed Care Pharmacy
Peer Review at PCORI August 26, 2013.
Primary Care Performance Measurement and Reporting
The Capture of Social and Behavioral Determinants of Health in
Pragmatic RCTs and the Learning Healthcare System
Jason Gerson, PhD Clinical Effectiveness and Decision Science
PCORI Research Priorities and Relevant Examples
Research & scholarship
Finance & Planning Committee of the San Francisco Health Commission
How to apply successfully to the NIHR HTA Board?
Sabaydee.
Regulatory Perspective of the Use of EHRs in RCTs
Penn State’s Center for Health Organization Transformation (CHOT)
Patient-Centered Outcomes Research Institute (PCORI)
Presentation Developed for the Academy of Managed Care Pharmacy
Registered Nurse’s Use of HIT, 2006: Findings from a National Survey
Evaluating the performance of advanced causal inference methods in real world data through large-scale replication of randomized controlled trials.
Data as the Passenger: The Importance of Identifying What Data Matters to the Community Courtney Clyatt Program Officer, Pipeline to Proposal Awards/Engagement.
REACHnet: Research Action for Health Network
Presentation transcript:

Improving PCOR Methods: Causal Inference Jason Gerson, PhD Associate Director CIMPOD 2016 February 25, 2016

Improving PCOR Methods: Why Methods Matter PCORI’s Mission PCORI was created to support research that provides high-integrity, evidence-based information to patients, clinicians, and the broader healthcare community. Why Methods Matter Rigorous research methods are needed to produce relevant, trustworthy findings that can improve patients’ healthcare outcomes. Methods for PCOR Methods include systematic processes, designs, tools, and techniques used to generate the evidence needed to answer questions about which healthcare options work best for particular patients.

Improving PCOR Methods: Program Goals Identify Methods Gaps Identify methodological gaps relevant to the conduct of PCOR Fund Research Fund high impact studies which address gaps in methodological research Disseminate Promising/Best Practices Disseminate and facilitate the adoption of new methods to improve the conduct of PCOR

Methods Program Overview 73 funded projects, $76 million awarded 25 states, DC, and Quebec Methods for Patient and Stakeholder Engagement Methods for Patient-Centered Outcomes and Patient-Reported Outcomes Research Related to the Ethical Conduct of PCOR/CER Methods to Improve Study Design Methods to Improve Validity and Efficiency of Analyses Methods to Support Data Research Networks

CER Methods Program Portfolio (73 projects as of 2/25/2016) Causal inference Heterogeneity of treatment effect Missing data Treatment adherence Some projects are classified in ≥1 category

Importance of CI Methods for PCOR/CER Many important clinical CER questions cannot be answered with RCTs (impossible/undesirable/unethical) – need for observational studies and to support improvements in their analytic methods. Comparison of complex treatment strategies sustained over long periods of time using data collected from routine clinical practice (or EHRs). Need to “transport” findings from our funded methodological projects to other parts of the PCORI portfolio, esp. large pragmatic studies and PCORnet. Intent of our investments in this area is to provide guidance/ recommendations to research community about what CI approaches are more or less optimal for a particular problem– toolkits, decision trees, standards, best practices.

Causal Inference for Effectiveness Research in Using Secondary Data Potential Impact Could change PCOR by improving methods for adjusting for confounding in observational studies, thereby improving the ability of those studies to generate robust findings Engagement A stakeholder advisory panel of 10 patients and will meet 5 times per year to provide feedback Methods Expansive simulation studies and clinically relevant sample studies to test and improve approaches for adjusting for confounding in database analyses Provides guidance on the optimal use of two innovative and highly promising approaches (high-dimensional propensity scoring and targeted maximum likelihood estimation) for robust confounding adjustment in database analyses. Sebastian Schneeweiss, MH, ScD MD, Brigham and Women’s Hospital Boston, MA CER Methods and Infrastructure, awarded September 2013

Causal analyses of electronic health record data for assessing the comparative effectiveness of treatment regimens Potential Impact Could change PCOR by improving existing causal inference methods for comparing complex treatment strategies and informing decision making by clinicians and patients for the management of chronic conditions Engagement A multi-stakeholder committee will inform and prioritize the development and dissemination of the proposed statistical methods Methods Simulation studies to evaluate the statistical methods; application of the methods to analyze EHR data from a recent observational study of type II diabetes Advances and adapts existing causal inference methods to improve evaluation of realistic adaptive treatment strategies that reflect real-world adherence to treatment decisions and recommended monitoring schedules. Romain Neugebauer, PhD Kaiser Foundation Research Institute Oakland, CA CER Methods and Infrastructure, awarded September 2014

Patient Centered Adaptive Treatment Strategies (PCATS) using Bayesian Causal Inference Potential Impact Could change PCOR by improving methods for analyzing data in cases where the treatment/exposures varies over time and improve clinical practice by developing evidence-based shared decision making tools for identifying optimal PCATS at the point-of- care. Engagement A stakeholder advisory panel including two parent representatives, and a partnership with PR-COIN (part of PCORnet) will ensure patient and stakeholder engagement throughout the research process, including in the design, conduct, analysis, and dissemination. Methods Bayesian modeling strategies, simulation studies, and empirical analyses of PCATS for polyarticular Juvenile Idiopathic Arthritis (pJIA). Develops Bayesian double robust causal inference methods for use in analyzing large registry and electronic health records to evaluate the clinical effectiveness of treatments and inform patient centered adaptive treatment strategies (PCATS). Bin Huang, PhD Cincinnati Children’s Hospital Medical Center Cincinnati, OH CER Methods and Infrastructure, awarded May 2015

Modeling Strategies for Observational CER: What Works Best When? Potential Impact Could change PCOR by helping researchers select the best method(s) for a particular observational dataset and CER question Methods Systematic review of existing literature on relevant analytical methods; simulations to assess performance of methods in cases where the literature is insufficient Develops a decision tool for use in selecting the most appropriate analytical methods to control bias from treatment self-selection (“confounding by indication”) in analyses of observational data for CER. Douglas Landsittel, PhD University of Pittsburgh Pittsburgh, PA CER Methods and Infrastructure, awarded December 2013

Development of a Causal Inference Toolkit for Patient- Centered Outcomes Research Potential Impact Could change PCOR by: 1) improving the validity of analytic methods for common applications; 2) enhancing the reproducibility, transparency, and replication of PCOR; and 3) improving the utility of “real-world” data in conducting PCOR studies Engagement A technical advisory panel will participate in approximately three conference calls per year to provide advice on this project Methods Develop guidelines for the use of inverse probability weighting and g-formula analytical techniques and software to facilitate the use of these techniques Develops a causal inference toolkit to provide a comprehensive, practical, and accessible guide to implementing inverse-probability weighting and the g-formula analytical techniques for PCOR studies using large observational data. Yi Zhang, MS, PhD Medical Technology & Practice Patterns Institute Bethesda, MD CER Methods and Infrastructure, awarded September 2013

Causal Inference Guidelines for Pragmatic Clinical Trials Potential Impact Provides investigators with better tools to estimate patient-centered effects in pragmatic clinical trials. Engagement Patients and stakeholders will be engaged in identifying the effects of interest in pragmatic trials and developing standards for estimating these effects. Methods Systematic review, focus groups, and case studies with supporting software will be used to create and implement a revised framework for the design and conduct of randomized pragmatic trials. Develops a set of causal inference standards specifically designed for the analysis of pragmatic clinical trials. Miguel Hernan, MPH, MD, DPH Harvard University School of Public Health Boston, MA CER Methods and Infrastructure, awarded September 2015

Thank you